
Encompass Health Corporation (NYSE:EHC – Free Report) – Investment analysts at Zacks Research increased their FY2026 EPS estimates for shares of Encompass Health in a report issued on Wednesday, November 18th. Zacks Research analyst Team now anticipates that the company will earn $6.24 per share for the year, up from their previous forecast of $6.03. The consensus estimate for Encompass Health’s current full-year earnings is $6.28 per share. Zacks Research also issued estimates for Encompass Health’s Q4 2026 earnings at $1.57 EPS, Q1 2027 earnings at $1.67 EPS, Q2 2027 earnings at $1.69 EPS, Q3 2027 earnings at $1.58 EPS, Q4 2027 earnings at $1.71 EPS, FY2027 earnings at $6.65 EPS, Q1 2028 earnings at $1.81 EPS, Q2 2028 earnings at $1.94 EPS, Q3 2028 earnings at $1.80 EPS and FY2028 earnings at $7.44 EPS.
Encompass Health (NYSE:EHC – Get Free Report) last released its earnings results on Wednesday, October 28th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.16. Encompass Health had a net margin of 10.17% and a return on equity of 18.35%. The business had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.60 billion. During the same period last year, the company earned $1.23 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis.
Read Our Latest Report on Encompass Health
Encompass Health Stock Performance
NYSE:EHC opened at $133.75 on Thursday. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.73. The company has a market cap of $13.12 billion, a P/E ratio of 20.90, a P/E/G ratio of 2.46 and a beta of 0.83. Encompass Health has a fifty-two week low of $92.77 and a fifty-two week high of $143.90. The firm’s 50 day moving average is $128.18 and its two-hundred day moving average is $113.06.
Hedge Funds Weigh In On Encompass Health
Hedge funds and other institutional investors have recently made changes to their positions in the business. Transamerica Financial Advisors LLC purchased a new position in Encompass Health in the second quarter valued at about $29,000. Toth Financial Advisory Corp acquired a new stake in Encompass Health during the 3rd quarter valued at approximately $38,000. Persistent Asset Partners Ltd purchased a new stake in Encompass Health during the 2nd quarter worth approximately $36,000. Keating Financial Advisory Services Inc. purchased a new stake in Encompass Health during the 2nd quarter worth approximately $39,000. Finally, Root Financial Partners LLC purchased a new stake in Encompass Health during the 3rd quarter worth approximately $52,000. Institutional investors and hedge funds own 97.25% of the company’s stock.
Insider Transactions at Encompass Health
In other Encompass Health news, EVP John Darby sold 4,858 shares of the business’s stock in a transaction that occurred on Monday, August 31st. The shares were sold at an average price of $121.09, for a total transaction of $588,255.22. Following the completion of the sale, the executive vice president directly owned 75,041 shares in the company, valued at $9,086,714.69. The trade was a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.80% of the stock is currently owned by corporate insiders.
Encompass Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Monday, January 4th. Encompass Health’s payout ratio is 13.12%.
Recent Encompass Health Headlines
These are some of the EHC headlines that stood out recently:
- Positive Sentiment: Zacks also increased estimates for multiple quarters through 2028, including Q2 2028 to $1.94 from $1.87. MarketBeat Encompass Health coverage
Encompass Health Company Profile
Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.
Read More
- Five stocks we like better than Encompass Health
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
